Literature DB >> 11340322

Lung cancer in the octogenarian.

K Kurishima1, H Satoh, H Ishikawa, Y T Yamashita, M Ohtsuka, K Sekizawa.   

Abstract

BACKGROUND: Older patients with lung cancer tend to have significant coexisting diseases and less aggressive treatment is often advisable.
OBJECTIVE: To investigate the clinicopathological features of lung cancer in patients aged 80 years and over.
METHODS: The medical records of 966 patients with lung cancer between 1976 and 1999 were reviewed retrospectively.
RESULTS: There were 56 (5.8%) patients 80 years old or over. Thirty-nine (70%) were male, and 22 (39%) patients had poor performance status (2-4). Some of the patients had a medical history of cardiovascular disease (n = 23; 41%), cerebrovascular disease (n = 5; 9%), diabetes mellitus (n = 11; 20%), or malignant disease (n = 8; 14%). Twenty-one (35%) patients were diagnosed as having surgically resectable disease and 20 patients underwent radiotherapy, but 25 patients only received supportive care because of concomitant illnesses. Only 9 and 2 patients, respectively, had chemotherapy and surgery. There was no statistical difference in the survival rate of the two groups of patients receiving radiotherapy or supportive care.
CONCLUSION: Adequate palliative care to provide prolonged quality survival is an appropriate primary goal of therapy for lung cancer in the octogenarian until less invasive treatments are developed. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11340322     DOI: 10.1159/000052790

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  2 in total

1.  Lung Cancer in the Oldest Old: A Nation-Wide Study in The Netherlands.

Authors:  Karlijn J G Schulkes; Carin A M Pouw; Elisabeth J M Driessen; Leontine J R van Elden; Frederiek van den Bos; Maryska L G Janssen-Heijnen; Jan-Willem J Lammers; Marije E Hamaker
Journal:  Lung       Date:  2017-06-19       Impact factor: 2.584

Review 2.  Non-small cell lung cancer in the elderly: defining treatment options.

Authors:  Nilesh Vora; Karen L Reckamp
Journal:  Semin Oncol       Date:  2008-12       Impact factor: 4.929

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.